Literature DB >> 27262370

Histopathologic Characteristics of Upper Tract Urothelial Carcinoma With an Emphasis on Their Effect on Cancer Survival: A Single-Institute Experience With 305 Patients With Long-Term Follow-Up.

Mohamed Mohamed Elawdy1, Diaa E Taha2, Mohamed A Elbaset2, Rasha T Abouelkheir3, Yasser Osman2.   

Abstract

INTRODUCTION: Tumor stage and grade represent the best established predictors for the prognosis of upper tract urothelial carcinoma (UTUC). However, controversies still exist regarding the role of tumor necrosis, location, and multifocality in the prognosis of UTUC. We share our experience with 305 patients, reporting on the pathologic features in detail, cancer characteristics, and survival.
MATERIALS AND METHODS: We retrospectively reviewed the data from patients who had undergone surgery for UTUC from 1983 to 2013. The tumors were staged according to the 1997 TNM classification and the 3-tiered World Health Organization grading system. Cancer-specific survival (CSS) was estimated using the Kaplan-Meier method.
RESULTS: A total of 305 patients were eligible for analysis. The 5-year CSS for grade 1, 2, and 3 was 88%, 84%, and 60%, respectively. The CSS for stage pT1, T2, T3, and T4 was 82%, 70%, 62%, and 0%, respectively. On univariate analysis, tumor stage, tumor grade, positive lymph node status, and micropapillary invasion had adverse effects on survival (P = .006, P = .045, P = .01, and P = .005, respectively). On multivariate analysis, only stage and micropapillary variant maintained significance (P = .01). Multicentricity and tumor location affected CSS in the early follow-up period but did not in the late follow-up period. Neither carcinoma in situ nor adverse pathologic variants affected survival.
CONCLUSION: The tumor stage and presence of a micropapillary variant are of paramount prognostic significance for survival in patients with UTUC. The tumor grade and lymph node status are also good predictors. In our series, multifocality and tumor location affected early and mid-term survival with no significant effects on late survival.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Kidney pelvic neoplasms; Survival; UTUC pathology; Ureteral neoplasms; Urologic neoplasms

Mesh:

Year:  2016        PMID: 27262370     DOI: 10.1016/j.clgc.2016.04.017

Source DB:  PubMed          Journal:  Clin Genitourin Cancer        ISSN: 1558-7673            Impact factor:   2.872


  8 in total

1.  Reflections on personalized management of UTUC.

Authors:  Marianne Brehmer
Journal:  World J Urol       Date:  2018-02-19       Impact factor: 4.226

2.  Long-term outcomes of upper tract urothelial carcinoma: A retrospective evaluation of single-center experience in 275 patients.

Authors:  Mohamed Mohamed Elawdy; Yasser Osman; Diaa Eldin Taha; Samer El-Halwagy; Mohamed Abd El-Hamid; Rasha T Abouelkheir
Journal:  Turk J Urol       Date:  2019-02-05

3.  Volumetric imaging: a potential tool to stage upper tract urothelial carcinoma.

Authors:  Alexandra Grahn; Nobuyuki Tanaka; Per Uhlén; Marianne Brehmer
Journal:  World J Urol       Date:  2019-02-28       Impact factor: 4.226

Review 4.  Consultation on UTUC, Stockholm 2018 aspects of risk stratification: long-term results and follow-up.

Authors:  Mudhar N Hasan; Morgan Rouprêt; Francis Keeley; Cecilia Cracco; Robert Jones; Michael Straub; Olivier Traxer; Palle Jörn Sloth Osther; Marianne Brehmer
Journal:  World J Urol       Date:  2019-04-03       Impact factor: 4.226

5.  Predicting invasiveness and disease-specific survival in upper tract urothelial carcinoma: identifying relevant clinical tumour characteristics.

Authors:  Camilla Malm; Alexandra Grahn; Georg Jaremko; Bernhard Tribukait; Marianne Brehmer
Journal:  World J Urol       Date:  2019-04-23       Impact factor: 4.226

Review 6.  Consultation on UTUC, Stockholm 2018: aspects of treatment.

Authors:  Helene Jung; Guido Giusti; Harun Fajkovic; Thomas Herrmann; Robert Jones; Michael Straub; Joyce Baard; Palle Jörn Sloth Osther; Marianne Brehmer
Journal:  World J Urol       Date:  2019-05-23       Impact factor: 4.226

Review 7.  Consultation on UTUC, Stockholm 2018 aspects of diagnosis of upper tract urothelial carcinoma.

Authors:  Grzegorz Fojecki; Anders Magnusson; Olivier Traxer; Joyce Baard; Palle Jörn Sloth Osther; Georg Jaremko; Christian Seitz; Thomas Knoll; Guido Giusti; Marianne Brehmer
Journal:  World J Urol       Date:  2019-03-26       Impact factor: 4.226

Review 8.  Impact of pathological factors on survival in patients with upper tract urothelial carcinoma: a systematic review and meta-analysis.

Authors:  Gopal Sharma; Anuj Kumar Yadav; Tarun Pareek; Pawan Kaundal; Shantanu Tyagi; Sudheer Kumar Devana; Shrawan Kumar Singh
Journal:  Int Braz J Urol       Date:  2022 May-Jun       Impact factor: 3.050

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.